Owkin
We find the right treatment for every patient.
Overview
Owkin has developed a platform that uses federated learning to allow researchers to train AI models on data from multiple sources without the data ever leaving its original location. This approach protects patient privacy while enabling the discovery of new biomarkers and the development of more effective and personalized treatments. They focus on oncology, immunology, and cardiovascular diseases.
β¨ Key Features
- Federated learning platform
- Secure analysis of distributed data
- Biomarker discovery
- Patient stratification
- AI-driven clinical trial optimization
π― Key Differentiators
- Use of federated learning to protect patient privacy.
- Access to a network of academic medical centers.
- Focus on multimodal patient data.
Unique Value: Enables the discovery of new drugs and biomarkers by securely analyzing sensitive patient data from multiple sources.
π― Use Cases (4)
β Best For
- Has established partnerships with major pharmaceutical companies and research institutions.
π‘ Check With Vendor
Verify these considerations match your specific requirements:
- NA
π Alternatives
Provides a privacy-preserving way to collaborate on sensitive data, which is a major challenge in healthcare.
π» Platforms
π Integrations
π Support Options
- β Email Support
- β Dedicated Support (Enterprise tier)
π Compliance & Security
π° Pricing
Free tier: NA
π Similar Tools in AI for Drug Discovery
Atomwise
Utilizes deep learning for structure-based drug discovery to find small molecule hits....
Insilico Medicine
An end-to-end AI-driven drug discovery platform covering target identification, molecule generation,...
Recursion Pharmaceuticals
Industrializes drug discovery by combining automated biology with artificial intelligence....
SchrΓΆdinger
Provides a physics-based software platform for molecular discovery and design....
Valo Health
A technology company using human-centric data and AI to transform drug discovery and development....
BenevolentAI
Applies AI and machine learning to analyze biomedical information and accelerate drug discovery....